Rate My Professor J. Andrew Orr-Skirvin

J. Andrew Orr-Skirvin, PharmD, RPh, BCOP, serves as Clinical Professor and Chair of the Department of Pharmacy and Health Systems Sciences in the School of Pharmacy at Northeastern University’s Bouvé College of Health Sciences. He is also Director of the Pharmaceutical Industry Fellowship Program and Director of Introductory Pharmacy Practice Experiences. Holding a co-appointment as Hematology/Oncology Clinical Pharmacist at Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston, Orr-Skirvin specializes in oncology pharmacy care with over 25 years of experience in clinical practice and pharmacy education. His research interests focus on supportive care for cancer patients, encompassing pain management, nausea and vomiting, neutropenic fever, long-term complications, and growth factor support.

Orr-Skirvin earned his Doctor of Pharmacy from the University of Texas at Austin and University of Texas Health Science Center at San Antonio in 1995, a Bachelor of Science in Pharmacy from Oregon State University in 1992 with summa cum laude honors, and completed an Oncology and Hematology Pharmacy Specialty Residency at Audie L. Murphy Memorial Veterans Hospital and University of Texas Health Science Center at San Antonio in 1996. Board Certified Oncology Pharmacist (BCOP), he previously served as Associate Clinical Professor with tenure at St. John’s University College of Pharmacy and Allied Health Professions from 2002 to 2007, Assistant Clinical Professor there from 1996 to 2002, and held clinical roles at North Shore University Hospital, University Hospital in San Antonio, and Oregon Health Sciences University. At Northeastern, he progressed from Associate Clinical Professor in 2007 to Clinical Professor in 2019 and Interim Department Chair in 2018 before becoming permanent Chair.

His scholarly contributions include peer-reviewed articles such as Fang K, Orr-Skirvin JA, Review of systemic lupus erythematosus, treatment, and future directions (US Pharm, 2019); Okwerekwu I, Skirvin JA, Sickle Cell Disease Pain Management (US Pharm, 2018); Skirvin JA, Principles of Pancreatic Cancer Management (US Pharm, 2016); and Skirvin JA, Lichtman SM, Pharmacokinetic considerations of oral chemotherapy in elderly cancer patients (Drugs Aging, 2002). Additional works cover thrombocytopenia, melanoma management, and antineoplastic pharmacology in older patients. Orr-Skirvin contributes Pharmacist Forum articles to Oncology Times on oncology therapeutics and has co-edited content on sickle cell disease for the National Academies of Sciences, Engineering, and Medicine (2020).